Elkem (ELK) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
9 Mar, 2026Opening remarks and agenda
Deputy chairman welcomed participants and provided practical information about the virtual meeting format and voting procedures.
Attendance included key executives and legal counsel, with a detailed breakdown of shares represented.
Specific resolutions to be voted on
Election of Hans Cappelen Arnesen as chair and Morten Viga as co-signer of the minutes was proposed and approved.
Approval of the notice and agenda for the meeting was proposed and passed.
Approval of a share purchase agreement with Bluestar was proposed and adopted.
Proposal for a share capital decrease related to the share purchase agreement was presented and approved.
Overview of voting outcomes
489,624,551 shares, representing 77.2% of share capital, participated in voting.
All proposed resolutions, including the share purchase agreement and share capital decrease, were approved.
Bluestar was excluded from voting on the share purchase agreement.
Latest events from Elkem
- Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 202513 Feb 2026 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 20243 Feb 2026 - EBITDA hit NOK 1,235 million, up 131% year-over-year, driven by Silicones and cost programs.ELK
Q3 202418 Jan 2026 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation14 Jan 2026 - 2024 saw strong financials, strategic portfolio review, and top-tier ESG achievements.ELK
DNB Small & Medium Enterprises Conference presentation14 Jan 2026 - Stable results amid weak markets, with Silicones improving and strategic review ongoing.ELK
Lunch presentation14 Jan 2026 - Divesting Silicones to focus on core growth, backed by strong financials and global leadership.ELK
SEB Nordic Seminar presentation14 Jan 2026 - Q4 EBITDA up 84% YoY; Silicones under review and classified as discontinued operations.ELK
Q4 202423 Dec 2025 - EBITDA up 25% to NOK 898m as Silicones review advances amid market uncertainty.ELK
Q1 202528 Nov 2025